Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Timing and cell specific system information handling for handover in evolved UTRA
Active and progressive targeted advertising
Radiation-curable ink composition, ink jet recording method, and recorded matter
Computer program and apparatus for evaluating signal propagation delays
Servo write assembly
Cake knife handle
Optical imaging device and imaging method for microscopy
  Randomly Featured Patents
Street lamp
Preparation of .alpha.-amino phosphonic acid derivatives
Method for fast bulk loading data into a database while bypassing exit routines
Devices and methods for interstitial injection of biologic agents into tissue
Stiffening member to increase fluid flow within a medical device
Method and apparatus for plating under constant current density
Candle lamp decoration
Method of operating a firing installation
Cooling container for cooling a semiconductor element
Mobile robot with a head-based movement mapping scheme